Literature DB >> 16618797

Requirement of clathrin heavy chain for p53-mediated transcription.

Masato Enari1, Kazuji Ohmori, Issay Kitabayashi, Yoichi Taya.   

Abstract

The p53 protein is a transcription factor that activates various genes responsible for growth arrest and/or apoptosis in response to DNA damage. Here, we report that clathrin heavy chain (CHC) binds to p53 and contributes to p53-mediated transcription. CHC is known to be a cytosolic protein that functions as a vesicle transporter. We found, however, that CHC exists not only in cytosol but also in nuclei. CHC expression enhances p53-dependent transactivation, whereas the reduction of CHC expression by RNA interference (RNAi) attenuates its transcriptional activity. Moreover, CHC binds to the p53-responsive promoter in vivo and stabilizes p53-p300 interaction to promote p53-mediated transcription. Thus, nuclear CHC is required for the transactivation of p53 target genes and plays a distinct role from clathrin-mediated endocytosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618797      PMCID: PMC1472469          DOI: 10.1101/gad.1381906

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  50 in total

Review 1.  Regulated portals of entry into the cell.

Authors:  Sean D Conner; Sandra L Schmid
Journal:  Nature       Date:  2003-03-06       Impact factor: 49.962

2.  p53 has a direct apoptogenic role at the mitochondria.

Authors:  Motohiro Mihara; Susan Erster; Alexander Zaika; Oleksi Petrenko; Thomas Chittenden; Petr Pancoska; Ute M Moll
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

3.  p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination.

Authors:  Steven P Linke; Sagar Sengupta; Nissim Khabie; Beth A Jeffries; Sabine Buchhop; Stefan Miska; Wilhelm Henning; Remy Pedeux; Xin W Wang; Lorne J Hofseth; Qin Yang; Susan H Garfield; Horst-Werner Stürzbecher; Curtis C Harris
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

4.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

Review 5.  Decision making by p53: life, death and cancer.

Authors:  M Oren
Journal:  Cell Death Differ       Date:  2003-04       Impact factor: 15.828

6.  Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1.

Authors:  Fernand Gobeil; Sylvie G Bernier; Alejandro Vazquez-Tello; Sonia Brault; Martin H Beauchamp; Christiane Quiniou; Anne Marilise Marrache; Daniella Checchin; Florian Sennlaub; Xin Hou; Mony Nader; Ghassan Bkaily; Alfredo Ribeiro-da-Silva; Edward J Goetzl; Sylvain Chemtob
Journal:  J Biol Chem       Date:  2003-07-07       Impact factor: 5.157

7.  A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).

Authors:  Pedram Argani; Man Yee Lui; Jérôme Couturier; Raymonde Bouvier; Jean-Christophe Fournet; Marc Ladanyi
Journal:  Oncogene       Date:  2003-08-14       Impact factor: 9.867

8.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

Review 9.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

10.  ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).

Authors:  Norio Chikatsu; Hiroshi Kojima; Kazumi Suzukawa; Atsushi Shinagawa; Toshiro Nagasawa; Hiroaki Ozawa; Yoriko Yamashita; Naoyoshi Mori
Journal:  Mod Pathol       Date:  2003-08       Impact factor: 7.842

View more
  26 in total

Review 1.  The endocytic matrix.

Authors:  Giorgio Scita; Pier Paolo Di Fiore
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

Review 2.  Protein adaptation: mitotic functions for membrane trafficking proteins.

Authors:  Stephen J Royle
Journal:  Nat Rev Mol Cell Biol       Date:  2013-08-14       Impact factor: 94.444

Review 3.  Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis.

Authors:  Beata Pyrzynska; Iwona Pilecka; Marta Miaczynska
Journal:  Mol Oncol       Date:  2009-06-11       Impact factor: 6.603

Review 4.  ChIPping away at gene regulation.

Authors:  Charles E Massie; Ian G Mills
Journal:  EMBO Rep       Date:  2008-04       Impact factor: 8.807

Review 5.  Taming the Triskelion: Bacterial Manipulation of Clathrin.

Authors:  Eleanor A Latomanski; Hayley J Newton
Journal:  Microbiol Mol Biol Rev       Date:  2019-02-27       Impact factor: 11.056

6.  NuMA is required for the selective induction of p53 target genes.

Authors:  Hirokazu Ohata; Makoto Miyazaki; Ryo Otomo; Yuko Matsushima-Hibiya; Chihiro Otsubo; Takahiro Nagase; Hirofumi Arakawa; Jun Yokota; Hitoshi Nakagama; Yoichi Taya; Masato Enari
Journal:  Mol Cell Biol       Date:  2013-04-15       Impact factor: 4.272

Review 7.  Unconventional functions for clathrin, ESCRTs, and other endocytic regulators in the cytoskeleton, cell cycle, nucleus, and beyond: links to human disease.

Authors:  Frances M Brodsky; R Thomas Sosa; Joel A Ybe; Theresa J O'Halloran
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-09-02       Impact factor: 10.005

8.  The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization.

Authors:  Monica Cubillos-Rojas; Fabiola Amair-Pinedo; Roser Peiró-Jordán; Ramon Bartrons; Francesc Ventura; Jose Luis Rosa
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

9.  A B-Myb complex containing clathrin and filamin is required for mitotic spindle function.

Authors:  Tomohiro Yamauchi; Takefumi Ishidao; Teruaki Nomura; Toshie Shinagawa; Yasunori Tanaka; Shigenobu Yonemura; Shunsuke Ishii
Journal:  EMBO J       Date:  2008-06-12       Impact factor: 11.598

10.  Nuclear localization of clathrin involves a labile helix outside the trimerization domain.

Authors:  Joel A Ybe; Sarah N Fontaine; Todd Stone; Jay Nix; Xiaoyan Lin; Sanjay Mishra
Journal:  FEBS Lett       Date:  2012-11-21       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.